| 标题 |
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Georg Lenz; M. Trněný; John M. Burke; Grzegorz S. Nowakowski; C.P. Fox; et al 出版日期:2026-05-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)